NEW YORK (GenomeWeb) – Molecular diagnostics firm Diamir announced today that it has formed a research collaboration with Janssen Pharmaceuticals, a unit of Johnson & Johnson, for the potential development of a microRNA-based companion diagnostic for neurodegenerative disease drug candidates.

Founded in 2009, Diamir is using its technology to develop assays that use blood-based miRNA signatures to diagnose neurodegenerative conditions including Alzheimer's disease, Parkinson's disease, and mild cognitive impairment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.